Jessica Wenthe

7PUBLICATIONS
16CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2026
Tumor microenvironment gene engineering with LOAd703 in patients with solid malignancies: LOKON002 phase I/IIb clinical trial.

|Mar 05, 2021
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.

Jessica Wenthe, Sedigheh Naseri, Alireza Labani-Motlagh

|Dec 15, 2020
Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Sandra Irenaeus, Vivan Hellström, Jessica Wenthe

|May 02, 2020
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40.

Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström

|Jan 09, 2019
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1.

Emma Eriksson, Ioanna Milenova, Jessica Wenthe

Pageof 2